Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head

American Journal of Surgery

Volumn 171, Issue 1, 1996, Pages 118-125

  Staley, Charles A ^a   Lee, Jeffrey E ^a   Cleary, Karen R ^a   Abbruzzese, James L ^a   Fenoglio, Claudia J ^a   Rich, Tyvin A ^a   Evans, Douglas B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE;

ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HUMAN; LAPAROTOMY; LIVER METASTASIS; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; SURGICAL MORTALITY; THORAX RADIOGRAPHY; TREATMENT FAILURE; TUMOR RECURRENCE;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; FLUOROURACIL; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PREOPERATIVE CARE; SURVIVAL RATE;

EID: 0030070277     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)80085-3     Document Type: Article

References (45)

1. Moertel CG, Childs DS Jr., Reitmeier RJ, et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet. 1969;2:865-867.
2. Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg. 1979;189:205-208.
3. Kaiser MH, Ellenberg SS. Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899-903.
4. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 1987;59:2006-2010.
5. Ishikawa O, Ohhigashi H, Teshima T, et al. Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreaticoduodenal region. J Surg Oncol. 1989;40:143-151.
6. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer. 1980;46:1945-1949.
7. Kopelson G. Curative surgery for adenocarcinoma of the pancreas ampulla of Vater: the role of adjuvant pre-or postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1983;9:911-915.
8. Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335-1339.
9. Fernandez-del Castillo C, Warshaw AL. Preoperative evaluation of adenocarcinoma of the pancreas: Massachusetts General Hospital experience. Cancer Bull. 1994;46:492-498.
10. Allema JH, Reinders ME, van Gulik TM, et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer. 1995;75:2069-2076.
11. Willet CG, Lewandrowski K, Warshaw AL, et al. Resection margins in carcinoma of the head of the pancreas: implications for radiation therapy. Ann Surg. 1993;217:144-148.
12. Yeo CJ, Cameron JL, Lillemore KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg. 1995;221:721-733.
13. Evans DB, Abbruzzese JL, Lee JE, et al. Preoperative chemoradiation and pancreatico-duodenectomy for the pancreas. Proc Am Soc Clin Oncol. 1994;13:226. Abstract.
14. Splinter TAW, Obertop H, Kok TC, Jeekel J. Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. J Cancer Res Clin Oncol. 1989;115: 200-202.
15. Evans DB, Termuhlen PM, Byrd DR, et al. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg. 1993; 218:54-60.
16. Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg. 1994;167: 104-113.
17. Leach SD, Rose JA, Lowy AM, et al. Significance of peritoneal cytology findings in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery. 1995; 118:472-478.
18. Evans DB, Abbruzzese JL, Cleary KR, et al. Rapid-fractionation preoperative chemoradiation for malignant periampullary neoplasms. J R Coll Surg Edinb. 1995;40:319-323.
19. Tyler DS, Evans DB. Reoperative pancreaticoduodenectomy. Ann Surg. 1994;219:211-221.
20. Staley CA, Cleary KR, Abbruzzese JL, et al. Need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas. In press.
21. Cusack JC, Fuhrman GM, Lee JE, et al. Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. Am J Surg. 1994;168:352-354.
22. Evans DB, Lee JE, Leach SD, et al. Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique. Adv Surg. 1995;29:235-262.
23. Bosset JF, Pavy JJ, Gillet M, et al. Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study. Radiother Oncol. 1992;24:191-194.
24. Foo ML, Gunderson LL, Nagorney DM, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracil. Int J Radiat Oncol Biol Phys. 1993; 26:483-489.
25. Griffin JF, Smalley SR, Jewell W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer. 1990;66:56-61.
26. Johnstone PA, Sindelar WF. Patterns of disease recurrence following definitive therapy of adenocarcinoma of the pancreas using surgery and adjuvant radiotherapy: correlations of a clinical trial. Int J Radiat Oncol Biol Phys. 1993;27:831-834.
27. Ozaki H. Improvement of pancreatic cancer treatment from the Japanese experience in the 1980s. Int J Radiat Oncol Biol Phys. 1992;12: 5-9.
28. Tepper J, Nardi G, Suit H. Carcinoma of the pancreas. Review of MGH experience from 1963 to 1973: analysis of surgical failure and implications for radiation therapy. Cancer. 1976;37:1519-1524.
29. Westerdahl J, Andrén-Sandeberg Å, Ihse I. Recurrence of exocrine pancreatic cancer - local or hepatic? Hepatogastroenterology. 1993;40: 384-387.
30. Whittington R, Bryer MP, Haller DG, et al. Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 1991;21:1137-1143.
31. Bakkevold KE, Kambestad B. Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater - the prognostic factors influencing the long-term results: a prospective multicentre study. Eur J Surg Oncol. 1993; 19:147-161.
32. Cameron JL, Crist DW, Sitzmann V, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991;161:120-125.
33. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68-73.
34. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995;221:59-66.
35. Roder JD, Stein HJ, Hüttl W, Siewert JR. Pylorus-preserving versus standard pancreaticoduodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg. 1992;79:152-155.
36. Trede M, Chir B, Schwall G, Saeger H. Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447-458.
37. Tsao JI, Rossi RL, Lowell JA. Pylorus-preserving pancreaticoduodenectomy. Arch Surg. 1994;129:405-412.
38. Zerbi A, Fossati V, Parolini D, et al. Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer. 1994;73:2930-2935.
39. Ishikawa O, Ohigashi H, Imaoka S, et al. Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch Surg. 1994;129: 1075-1080.
40. Evans DB, Abbruzzese JL, Cleary KR, et al. Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. Int J Radiat Oncol Biol Phys. 1995;33: 913-918.
41. Evans DB, Abbruzzese JL, Lee JE, et al. Preoperative chemoradiation for adenocarcinoma of the pancreas: M. D. Anderson experience. Semin Surg Oncol. 1995;11:132-140.
42. Robins DB, Katz RL, Evans DB, et al. Fine-needle aspiration of the pancreas: in quest of accuracy. Acta Cytol. 1995;39:1-10.
43. Roder JD, Stein HJ, Siewert R. Carcinoma of the periampullary region: who benefits from portal vein resection? Gastroenterology. 1995;108:1242. Abstract.
44. Fuhrman GM, Leach SD, Staley CA. Rationale for en-bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg. In press.
45. Leach SD, Lowy AM, Fuhrman GM, et al. Pancreatic malignancy involving the superior mesenteric-portal vein confluence is not a contraindication to pancreaticoduodenectomy. Gastroenterology. 1995; 108:1228. Abstract.